Paper Details

  1. Home
  2. Paper Details

Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.

Author: , ClarkeCarl E, DeaneKatherine, FurmstonAlex, GrayRichard, HandleyKelly, IvesNatalie, StoweRebecca, WheatleyKeith

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

A common problem for people with Parkinson's disease (PD) who take levodopa long-term is the development of movement problems. When this happens, doctors often add another medication to the levodopa, usually from one of three groups of Parkinson's medications (dopamine agonists, catechol-O-methyl transferase inhibitors, or monoamine oxidase type B inhibitors). While these medications have shown benefit compared to placebo, the best way to treat these movement problems and whether one type of medication is better than another is still unclear.
Paper Details　
Original Abstract of the Article :
One of the complications of long-term treatment of Parkinson's disease (PD) with levodopa is the development of motor complications. Generally, when motor complications develop, clinicians add in an additional drug (to the levodopa regimen) from one of three other classes of anti-Parkinsonian treatm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD007166.pub2

データ提供：米国国立医学図書館（NLM）

Navigating the Parkinson's Desert: Seeking Solutions for Motor Complications

The [Parkinson's disease] journey is a challenging one, marked by progressive motor dysfunction. This study delves into the complexities of managing [motor complications] that arise from long-term [levodopa] therapy. Imagine a vast desert landscape, where individuals with Parkinson's disease, like weary travelers, struggle to navigate the shifting sands of their symptoms. This research explores strategies for managing motor complications, seeking to alleviate the burden of these debilitating conditions.

A Multifaceted Approach: Treating Motor Complications in Parkinson's Disease

The study highlights the use of additional medications, like [dopamine agonists], [catechol-O-methyl transferase inhibitors (COMTIs)], and [monoamine oxidase type B inhibitors (MAOBIs)], to manage motor complications. These medications, like desert oases offering respite from the harsh conditions, aim to improve motor function and reduce symptoms. However, the study acknowledges the need for further research to determine the most effective approach and the relative efficacy of different drug classes.

A Personalized Approach: Tailoring Treatment for Parkinson's Disease

The study emphasizes the importance of a personalized approach to managing motor complications in Parkinson's disease. It highlights the need for careful consideration of each individual's specific needs and preferences when selecting the most appropriate treatment strategy. Imagine a diverse group of travelers crossing the desert, each with unique needs and preferences. This research underscores the importance of providing personalized care to those navigating the challenges of Parkinson's disease.

Dr.Camel's Conclusion

This study reminds us that Parkinson's disease, like a vast and unforgiving desert, presents complex challenges. The research underscores the importance of exploring various treatment strategies and tailoring care to individual needs. As Dr. Camel, I encourage individuals with Parkinson's disease to work closely with their healthcare providers to find the most effective approach to managing their symptoms.

Date :
  1. Date Completed 2010-08-11
  2. Date Revised 2021-10-28
Further Info :

Pubmed ID

20614454

DOI: Digital Object Identifier

10.1002/14651858.CD007166.pub2

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.